| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2022 | LQDA Liquidia Corp | Kaseta Michael57 | Chief Financial Officer | Buy | 1,927 | $4.90 | $9,450.97 | +6.9% | -16.1% | +19.1% | |
| Aug 31, 2022 | VRNO Verano Holdings Corp. | Weiss Darren Henry | COO, CLO, GC And Secretary | Sell | 56,517 | $6.52 | $368,694.30 | -9.0% | - | - | |
| Aug 31, 2022 | VRNO Verano Holdings Corp. | Spreckman David | EVP, Marketing | Sell | 607 | $6.52 | $3,959.83 | -16.7% | - | - | |
| Aug 26, 2022 | PLSH Panacea Life Sciences Holdings, Inc. | Buttorff Leslie | CEO | Buy | 15,000 | $0.14 | $2,048.45 | +0.8% | - | - | |
| Aug 24, 2022 | TKNO Alpha Teknova, Inc. | MacKowski J Matthew | Director | Buy | 10,000 | $4.98 | $49,750.00 | New | -2.0% | -50.1% | |
| Aug 23, 2022 | UTHR United Therapeutics Corp | Causey Christopher59 | Director | Sell | 3,500 | $224.96 | $787,359.65 | -55.2% | +17.3% | +2.2% | |
| Aug 22, 2022 | TEVA Teva Pharmaceutical Industries Ltd | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sell | 55,500 | $10.07 | $558,696.30 | -85.5% | -13.1% | -4.0% | |
| Aug 22, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Martin Tami Tillotson54 | Sr. V.p., Regulatory Affairs | Sell | 5,000 | $35.98 | $179,900.00 | -5.4% | -1.9% | -9.5% | |
| Aug 18, 2022 | LNTH Lantheus Holdings, Inc. | Blanchfield Paul54 | Chief Operating Officer | Sell | 1,500 | $83.39 | $125,085.00 | -1.9% | -32.4% | -19.7% | |
| Aug 17, 2022 | VTRS Viatris Inc | Van Der Meer Mohr Pauline | Director | Sell | 9,440 | $10.58 | $99,912.02 | -31.5% | +6.5% | +7.9% | |
| Aug 17, 2022 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 199 | $6.82 | $1,356.19 | -0.4% | +4.3% | -79.4% | |
| Aug 16, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 14,690 | $34.01 | $499,650.97 | -1.9% | +1.5% | -8.9% | |
| Aug 16, 2022 | TKNO Alpha Teknova, Inc. | Grossman Paul David | Director | Buy | 9,212 | $5.37 | $49,504.01 | +190.9% | -8.3% | -48.3% | |
| Aug 15, 2022 | IRWD Ironwood Pharmaceuticals Inc | John Minardo69 | Chief Legal Officer | Sell | 7,330 | $11.77 | $86,274.10 | -5.0% | -3.8% | -17.2% | |
| Aug 15, 2022 | IRWD Ironwood Pharmaceuticals Inc | Rickard Jason65 | SVP, Chief Operating Officer | Sell | 994 | $11.77 | $11,699.38 | -0.3% | -3.8% | -17.2% | |
| Aug 15, 2022 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 386 | $82.82 | $31,968.52 | -0.6% | -31.6% | -18.2% | |
| Aug 15, 2022 | DVAX Dynavax Technologies Corp | Hack Andrew A. F.62 | Director | Sell | 3,000,000 | $14.68 | $44,040,000.00 | -35.7% | -17.7% | -8.1% | |
| Aug 15, 2022 | IRWD Ironwood Pharmaceuticals Inc | Silver Ronald68 | Principal Accounting Officer | Sell | 2,014 | $11.77 | $23,704.78 | -1.9% | -3.8% | -17.2% | |
| Aug 15, 2022 | LNTH Lantheus Holdings, Inc. | Marshall Robert J. Jr.53 | CFO And Treasurer | Sell | 5,000 | $82.82 | $414,100.00 | -3.7% | -31.6% | -18.2% | |
| Aug 15, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 17,302 | $34.03 | $588,752.46 | -2.2% | +1.5% | -6.3% | |
| Aug 15, 2022 | TKNO Alpha Teknova, Inc. | Gunstream Stephen47 | President And CEO | Buy | 18,000 | $5.13 | $92,338.20 | New | -3.8% | -46.3% | |
| Aug 15, 2022 | ANIP Ani Pharmaceuticals Inc | Marken James G.47 | SVP Ops &Prod Dev | Sell | 18,066 | $37.26 | $673,069.21 | -7.0% | -3.6% | +63.6% | |
| Aug 15, 2022 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 3,566 | $2.31 | $8,240.72 | - | -3.8% | -32.3% | |
| Aug 15, 2022 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 2,125 | $2.31 | $4,912.41 | +0.2% | -3.8% | -32.3% | |
| Aug 15, 2022 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 1,057 | $2.31 | $2,445.99 | +0.2% | -3.8% | -32.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.